Showing 1 - 10 of 7,719
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static … adoption of generic competition. This paper aims to investigate how price regulations in the OECD affect the adoption of … generic competition following the first global generic launch of each molecule. Drawing upon data from 1999 to 2008, we …
Persistent link: https://www.econbiz.de/10013068052
more agressive, which triggers price competition and potentially deters entry by generic producers. To investigate the … branded and generic drug prices and branded market shares. Despite fiercer price competition, the number of generic producers …
Persistent link: https://www.econbiz.de/10013285854
Persistent link: https://www.econbiz.de/10010425130
Persistent link: https://www.econbiz.de/10011476934
Many countries with national health care providers and health insurances regulate the market for pharmaceuticals to … drug substitution and competition. Since 2006, Germany follows an innovative approach by differentiating drug co … potential reductions in co-payments. We refer to the latter result as the "co-payment exemption paradox." Our competition proxy …
Persistent link: https://www.econbiz.de/10009522774
After the Supreme Court's gift of blanket immunity to generic drug manufacturers, these companies are dancing on the graves of their victims. In fact, one generic pharmaceutical defendant in a recent pre-trial motion actually alleged that “federal law allows it to ‘[keep] quiet its knowledge...
Persistent link: https://www.econbiz.de/10012987195
Persistent link: https://www.econbiz.de/10001786600
Persistent link: https://www.econbiz.de/10012598470
Persistent link: https://www.econbiz.de/10011713223
Persistent link: https://www.econbiz.de/10011713225